The emerging treatment of the medication represents a major breakthrough in the handling of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide460401.howeweb.com/42652936/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment